EarliPoint provides an objective, validated, predictive biomarker for ASD with the potential to reduce the time between the first signs of autism and intervention.
#TheDefender
https://childrenshealthdefense.org/defender/eye-test-earlipoint-autism/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20230913
In a study published in JAMA Network, the EarliPoint eye test confirmed the majority of doctor-diagnosed autism spectrum disorder (ASD) cases and distinguished them from children without ASD but who exhibited some of the same symptoms.
childrenshealthdefense.org
0
Share on Telegram
Share on Facebook
Share on Twitter
Share on Reddit